HeartBeam to Present Results of ALIGN-ACS Study for Heart Attack Assessment at TCT 2026 on November 1, 2026Business Wire • Wednesday
HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam TechnologyBusiness Wire • 10/21/26
HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk PatientsBusiness Wire • 10/15/26
HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack AssessmentBusiness Wire • 10/05/26
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern TimeBusiness Wire • 07/30/26
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of ScheduleBusiness Wire • 06/30/26
HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership TransitionBusiness Wire • 06/24/26
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at HomeBusiness Wire • 06/02/26
HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the ClinicBusiness Wire • 05/11/26
HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge PracticeBusiness Wire • 05/07/26
HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern TimeBusiness Wire • 04/30/26